Literature DB >> 1311602

Primary cutaneous aspergillosis in a heart transplant recipient treated with surgical excision and oral itraconazole.

K M Loria1, M H Salinger, T G Frohlich, M D Gendelman, F V Cook, C E Arentzen.   

Abstract

A 24-year-old man underwent orthotopic heart transplantation for treatment of end-stage complex congenital heart disease. Six weeks postoperatively, five erythematous skin lesions developed on the patient's right forearm. Punch biopsy revealed Aspergillus. Despite extensive testing, no other potential primary site was located. Because of concern of dissemination, the patient was treated with a combination of local debridement and systemic antifungal therapy with itraconazole. He is presently without signs or symptoms of recurrent disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311602

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

Review 1.  Cutaneous aspergillosis.

Authors:  J A van Burik; R Colven; D H Spach
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  First reported case of Aspergillus granulosus infection in a cardiac transplant patient.

Authors:  M G Fakih; G E Barden; C A Oakes; C S Berenson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  Primary cutaneous aspergillosis in an immunocompetent patient.

Authors:  Chubado Tahir; Musa Garbati; Haruna A Nggada; Edith H Terna Yawe; Auwal M Abubakar
Journal:  J Surg Tech Case Rep       Date:  2011-07

Review 5.  Factors affecting patient outcome in primary cutaneous aspergillosis.

Authors:  Alexander M Tatara; Antonios G Mikos; Dimitrios P Kontoyiannis
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.